Ipsen is strengthening its ties to long-time development partner Oncodesign, a Dijon-based cancer treatment...
Up To Date
Latest News
Swiss bank Group UBS has raised US$471m (€412m) for the UBS Oncology Impact Fund, which was set up to invest...
More revenue, more jobs, more financing, more R&D expenditure – all signs point towards sustainable growth in...
An expert panel’s final report on the fatal drug trial earlier this year in France states that the death of...
For up to US$685m (€606m), Dutch ArgenX has outlicensed its human antibody programme ARGX-115 to AbbVie. The...
Despite political disturbances, 2015 was a good year for the biotech scene in Switzerland. Net sales increased...
Share
